Investing.com - Viatris reported on Monday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Viatris announced earnings per share of $0.26 on revenue of $4.12B. Analysts polled by Investing.com anticipated EPS of $0.8279 on revenue of $4.18B.
Viatris shares are down 28.09% from the beginning of the year and are trading at $9.73 , down-from-52-week-high.They are under-performing the S&P 500 which is down 13.03% from the start of the year.
Viatris follows other major Healthcare sector earnings this month
Viatris's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar